Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism

Curr Cardiol Rep. 2023 Aug;25(8):863-878. doi: 10.1007/s11886-023-01906-6. Epub 2023 Jul 26.

Abstract

Purpose of review: The article aims to investigate the complex relationship between cancer and cardiovascular disease (CVD), with a focus on the effects of cancer treatment on cardiac health.

Recent findings: Advances in cancer treatment have improved long-term survival rates, but CVD has emerged as a leading cause of morbidity and mortality in cancer patients. The interplay between cancer itself, treatment methods, homeostatic changes, and lifestyle modifications contributes to this comorbidity. Recent research in the field of cardio-oncology has revealed common genetic mutations, risk factors, and metabolic features associated with the co-occurrence of cancer and CVD. This article provides a comprehensive review of the latest research in cardio-oncology, including common genetic mutations, risk factors, and metabolic features, and explores the interactions between cancer treatment and CVD drugs, proposing novel approaches for the management of cancer and CVD.

Keywords: Cardio-oncology; Cardiotoxicity; Gene mutation; Metabolism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Cardiotoxicity / drug therapy
  • Cardiotoxicity / etiology
  • Cardiovascular Diseases* / etiology
  • Humans
  • Medical Oncology
  • Neoplasms* / complications
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics

Substances

  • Antineoplastic Agents